Radoff Amends Stake in Lifevantage Corp

TL;DR

Radoff updated his Lifevantage stake filing on 7/31. Check for changes.

AI Summary

Bradley L. Radoff has amended his Schedule 13D filing regarding Lifevantage Corporation, as of July 31, 2024. The filing indicates a change in beneficial ownership of the company's common stock. Radoff's address is listed as 2727 Kirby Drive, Unit 29L, Houston, Texas 77098.

Why It Matters

This amendment to a Schedule 13D filing signals a potential shift in significant shareholder influence or strategy for Lifevantage Corporation, which could impact its stock price and corporate governance.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant investor activity, which can lead to volatility and strategic changes for the company.

Key Players & Entities

• Lifevantage Corporation (company) — Subject Company
• Bradley L. Radoff (person) — Filer
• Ryan Nebel Olshan Frome Wolosky LLP (company) — Legal Counsel

FAQ

Key Financial Figures

• $0.0001 — ame of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 53222
• $417,710 — the Radoff Foundation is approximately $417,710, including brokerage commissions. The
• $2,096,633 — ly owned by Mr. Radoff is approximately $2,096,633, including brokerage commissions. Item

Filing Documents

• sc13da409076057_07312024.htm (SC 13D/A) — 81KB
• 0000921895-24-001653.txt ( ) — 82KB

Source and Amount of Funds or Other Consideration

Item 3. Source and Amount of Funds or Other Consideration .

is hereby amended

Item 3 is hereby amended and restated to read as follows: The Shares purchased by the Radoff Foundation were purchased with working capital. The aggregate purchase price of the 82,500 Shares directly owned by the Radoff Foundation is approximately $417,710, including brokerage commissions. The Shares directly owned by Mr. Radoff were purchased with personal funds. The aggregate purchase price of the 551,500 Shares directly owned by Mr. Radoff is approximately $2,096,633, including brokerage commissions.

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer . Items 5(a) – (c) and (e) are hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based upon 12,700,556 Shares outstanding as of May 1, 2024, which is the total number of Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 2, 2024. A. The Radoff Foundation (a) As of the date hereof, the Radoff Foundation beneficially owns directly 82,500 Shares. Percentage: Less than 1% (b) 1. Sole power to vote or direct vote: 82,500 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 82,500 4. Shared power to dispose or direct the disposition: 0 B. Mr. Radoff (a) As of the date hereof, Mr. Radoff beneficially owns directly 551,500 Shares. As a director of the Radoff Foundation, Mr. Radoff may be deemed to beneficially own the 82,500 Shares owned by the Radoff Foundation. Percentage: Approximately 4.99% (b) 1. Sole power to vote or direct vote: 634,000 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 634,000 4. Shared power to dispose or direct the disposition: 0 4 CUSIP No. 53222K205 The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Exchange Act, the beneficial Shares that he or it does not directly own. (c) Schedule B annexed hereto lists all transactions in securities of the Issuer by the Reporting Persons during the past 60 days. All of such transactions were effected in the open market unless otherwise noted therein. (e) As of July 31, 2024, the Reporting Persons ceased to be the beneficial owners of more than 5% of the Shares of the

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: July 31, 2024 The Radoff Family Foundation By: /s/ Bradley L. Radoff Name: Bradley L. Radoff Title: Director /s/ Bradley L. Radoff Bradley L. Radoff 6 CUSIP No. 53222K205 SCHEDULE B Transactions in the Securities of the Issuer During the Past Sixty (60) Days Nature of the Transaction Amount of Securities Purchased/(Sold) Price ($) Date of Purchase/Sale THE RADOFF FAMILY FOUNDATION Purchase of Common Stock 1,000 6.3609 07/03/2024 Purchase of Common Stock 2,500 5.7789 07/08/2024 Purchase of Common Stock 5,000 5.5694 07/09/2024 Purchase of Common Stock 2,500 6.3358 07/15/2024 BRADLEY L. RADOFF Sale of Common Stock (1,000) 7.9990 06/03/2024 Purchase of Common Stock 11,950 6.4091 06/24/2024 Purchase of Common Stock 5,000 6.3080 07/01/2024 Purchase of Common Stock 4,000 6.2218 07/05/2024 Purchase of Common Stock 6,000 5.8864 07/08/2024 Purchase of Common Stock 10,000 5.6157 07/09/2024 Purchase of Common Stock 1,000 6.1673 07/11/2024 Purchase of Common Stock 4,000 6.4034 07/16/2024 Purchase of Common Stock 7,500 6.4153 07/18/2024 Purchase of Common Stock 2,500 6.7236 07/22/2024 Sale of Common Stock (148,000) 8.3214 07/29/2024 Sale of Common Stock (8,600) 8.4577 07/30/2024 Sale of Common Stock (32,000) 7.9561 07/31/2024

View Full Filing

View this SC 13D/A filing on SEC EDGAR